Saved in:
| Main Authors: | Brandon M. Roberts, Adam W. Potter, Geoffrey C. Chin, Karl E. Friedl |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/oby.24136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Family Considerations in the Treatment of Adult Obesity With Antiobesity Medications
by: Keeley J. Pratt, et al.
Published: (2025)
by: Keeley J. Pratt, et al.
Published: (2025)
Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management Treatment
by: Rebecca A. Jones, et al.
Published: (2026)
by: Rebecca A. Jones, et al.
Published: (2026)
Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown
by: Anna Pendrey, et al.
Published: (2025)
by: Anna Pendrey, et al.
Published: (2025)
Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
by: Jie‐Syuan Wu, et al.
Published: (2026)
by: Jie‐Syuan Wu, et al.
Published: (2026)
Overweight/obesity, gestational weight gain, postpartum weight retention, and maternal/neonatal complications in the military
by: Rebecca A. Krukowski, et al.
Published: (2024)
by: Rebecca A. Krukowski, et al.
Published: (2024)
Nutritional considerations with antiobesity medications
by: Jaime P. Almandoz, et al.
Published: (2024)
by: Jaime P. Almandoz, et al.
Published: (2024)
Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
by: Jamy D. Ard, et al.
Published: (2024)
by: Jamy D. Ard, et al.
Published: (2024)
Net prices of new antiobesity medications
by: Inmaculada Hernandez, et al.
Published: (2024)
by: Inmaculada Hernandez, et al.
Published: (2024)
Response to “Nutritional considerations with antiobesity medications”
by: Shaminie J. Athinarayanan
Published: (2024)
by: Shaminie J. Athinarayanan
Published: (2024)
Response to “Nutritional considerations with antiobesity medications”
by: Gabriela de Souza Bett, et al.
Published: (2024)
by: Gabriela de Souza Bett, et al.
Published: (2024)
Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
by: Sheila Pintado-Cucarella
Published: (2016)
by: Sheila Pintado-Cucarella
Published: (2016)
The association between weight loss medications and cardiovascular complications
by: Onur Baser, et al.
Published: (2024)
by: Onur Baser, et al.
Published: (2024)
Response to “Response to review by Pan et al.”
by: Xin‐Hui Pan, et al.
Published: (2024)
by: Xin‐Hui Pan, et al.
Published: (2024)
Weight management medications for chronic use in 37 veterans affairs medical centers—A medication use evaluation
by: Samantha Walczuk, et al.
Published: (2024)
by: Samantha Walczuk, et al.
Published: (2024)
Determinants of adherence to obesity medication: A narrative review
by: Arya M. Sharma, et al.
Published: (2025)
by: Arya M. Sharma, et al.
Published: (2025)
The vices and virtues of medical models of obesity
by: Jonathan Sholl, et al.
Published: (2024)
by: Jonathan Sholl, et al.
Published: (2024)
M RI assessment of adipose tissue fatty acid composition in the UK Biobank and its association with diet and disease
by: Marjola Thanaj, et al.
Published: (2024)
by: Marjola Thanaj, et al.
Published: (2024)
Obesity and postpartum hospital use among individuals without additional medical comorbidities
by: Kimberly B. Glazer, et al.
Published: (2024)
by: Kimberly B. Glazer, et al.
Published: (2024)
Managing the new wave of weight loss medication in general practice: A qualitative study
by: Pernille Andreassen, et al.
Published: (2024)
by: Pernille Andreassen, et al.
Published: (2024)
Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
by: Lee M. Kaplan, et al.
Published: (2025)
by: Lee M. Kaplan, et al.
Published: (2025)
Unraveling the roles of ectopic adipose depots and physical activity in age‐related mitochondrial decline
by: Brian A. Irving, et al.
Published: (2024)
by: Brian A. Irving, et al.
Published: (2024)
Primary care perspectives on prescribing anti‐obesity medication for adolescents
by: Rutha Chivate, et al.
Published: (2024)
by: Rutha Chivate, et al.
Published: (2024)
Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
by: Stephanie A. Hooker, et al.
Published: (2026)
by: Stephanie A. Hooker, et al.
Published: (2026)
The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea
by: Brian W. Locke, et al.
Published: (2024)
by: Brian W. Locke, et al.
Published: (2024)
Evaluation of prescription medication changes following sleeve gastrectomy surgery
by: Gina Arena, et al.
Published: (2024)
by: Gina Arena, et al.
Published: (2024)
Development and validation of an eating behavior patient‐reported outcome measure in people living with obesity or overweight
by: Donald M. Bushnell, et al.
Published: (2025)
by: Donald M. Bushnell, et al.
Published: (2025)
The associations of “weekend warrior” and regularly active physical activity with abdominal and general adiposity in US adults
by: Lubi Lei, et al.
Published: (2024)
by: Lubi Lei, et al.
Published: (2024)
Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
by: Nora Hennies, et al.
Published: (2024)
by: Nora Hennies, et al.
Published: (2024)
Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase
by: Carmen Merali, et al.
Published: (2024)
by: Carmen Merali, et al.
Published: (2024)
Adipose Tissue Analysis Toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue
by: Jacob J. Robino, et al.
Published: (2024)
by: Jacob J. Robino, et al.
Published: (2024)
Enfoque de la obesidad infantil desde la pediatría
by: Erika F. Hurtado-López
Published: (2014)
by: Erika F. Hurtado-López
Published: (2014)
Four‐year follow‐up of weight loss maintenance using electronic medical record data: The PROPEL trial
by: Peter T. Katzmarzyk, et al.
Published: (2024)
by: Peter T. Katzmarzyk, et al.
Published: (2024)
Association of ‘weekend warrior’ and other leisure time physical activity patterns with obesity and adiposity: A cross‐sectional study
by: Stanley Sai‐chuen Hui, et al.
Published: (2024)
by: Stanley Sai‐chuen Hui, et al.
Published: (2024)
Genetic Determinants of Fatty Acid Composition in Subcutaneous and Visceral Adipose Tissue
by: Altayeb Ahmed, et al.
Published: (2025)
by: Altayeb Ahmed, et al.
Published: (2025)
Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery
by: Jason M. Samuels, et al.
Published: (2024)
by: Jason M. Samuels, et al.
Published: (2024)
Measurement and evaluation of community engagement in complex, chronic medical conditions: HIV and obesity as exemplar conditions
by: Andrew D. Brown, et al.
Published: (2025)
by: Andrew D. Brown, et al.
Published: (2025)
Changes in insulin sensitivity and gut peptides 8 and 52 weeks after bariatric surgery or low‐calorie diet
by: Adam C. Lowe, et al.
Published: (2024)
by: Adam C. Lowe, et al.
Published: (2024)
Changes in energy expenditure and physical activity over 15 years of environmental changes: The Maycoba project
by: Alexandra Niclou, et al.
Published: (2024)
by: Alexandra Niclou, et al.
Published: (2024)
Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
by: Crystal M. Y. Lee, et al.
Published: (2025)
by: Crystal M. Y. Lee, et al.
Published: (2025)
Correction to “Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time”
Published: (2024)
Published: (2024)
Similar Items
-
Family Considerations in the Treatment of Adult Obesity With Antiobesity Medications
by: Keeley J. Pratt, et al.
Published: (2025) -
Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management Treatment
by: Rebecca A. Jones, et al.
Published: (2026) -
Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown
by: Anna Pendrey, et al.
Published: (2025) -
Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
by: Jie‐Syuan Wu, et al.
Published: (2026) -
Overweight/obesity, gestational weight gain, postpartum weight retention, and maternal/neonatal complications in the military
by: Rebecca A. Krukowski, et al.
Published: (2024)